FindTrial
Sign In

TCD combined with NIRS monitoring was used to evaluate the effect of selective antegrade cerebral perfusion during TAR

TCD combined with NIRS monitoring was used to evaluate the effect of selective antegrade cerebral perfusion during TAR

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093543
Enrollment
Unknown
Registered
2024-12-06
Start date
2024-12-06
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic dissection

Interventions

Unilateral cerebral perfusion group(u-SACP):None
Bilateral cerebral perfusion group(b-SACP):None

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Patients undergoing total arch replacement at our medical center; 2. Age >18 years old, regardless of gender; 3. ASA Grade III or IV.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patients with temporal window closed or middle cerebral artery could not be detected due to technical reasons; 2. The patient or family declined to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Cerebral perfusion effect;—

Secondary

MeasureTime frame
The incidence of postoperative stroke;All cause death occurred during hospitalization;The incidence of postoperative delirium;Postoperative mechanical ventilation time;Length of ICU stay;Length of stay;—

Countries

China

Contacts

Public ContactJiangli Wu

The Second Hospital of Hebei Medical University

28704105@hebmu.edu.cn+86 150 7640 2388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026